Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Fully agree. I expect pilot batches this week or next.
A little snippet from today in Parliament - Saliva testing in the pipeline. Working hard to trial this tech he said...
Clip here https://twitter.com/buy_buy_bye/status/1313147461028974593?s=20
They are using the Abbott test I believe.
We're not exactly speeding - haha. The BAMS test needs to complete validation in UK and Stateside and will no doubt receive FDA approval too in due course.
Absolute rubbish. It will open at 174/176 unless there is any news. Happens all the time. The UT means very little.
Don’t believe anything other than the truth. Seen this countless times.
Video here - https://twitter.com/buy_buy_bye/status/1308492829539414017?s=20
I'm doubtful this would pass a UK validation study to be honest...
Good thing is we know this isn’t the end game. it’s a stop gap. Saliva is clearly the end game
Seen some reference to a 30 minute lateral flow antigen test.... From my research it seems this test is the SD bio test... This has been used in India for sometime but the S/S has been debatable... Especially when you add in the errors for Nasal swab sample collection...
http://sdbiosensor.com/xe/product/7672
It's a Nasal swab test...
“Before its approval by ICMR and the All India Institute of Medical Devices, AIMS-DEHLI, two clinical studies evaluated the test and reported a 99.3%-100% specificity and 50.6%-84% sensitivity. One of these studies was performed in Malaysia, which has now since implemented the kit into its testing regime along with Colombia.”
More info and video in these links..
https://www.oxfordbiosystems.com/COVID-19-Antigen-screening-and-blood-tests#:~:text=Standard%20Q%20COVID%2D19%20Ag%20kit&text=Results%20were%20compared%20to%20a,was%20shown%20to%20be%2084.38%25.
https://www.rapidmicrobiology.com/news/india-council-release-data-on-high-volume-covid-19-antigen-testing-regime
https://photos.google.com/share/AF1QipO_pkgugFEOF25DRR5UkjztGpMeNsBKaTI7JhMnldq3CxoqRN5RqYg6s_Uylcuvpg/photo/AF1QipMYLXXcMtkBvUeGXVfjVR4J--Vu_WNWmGY1zCAU?key=MWxqRzlFeE1vQUxsU2M5TXNGM2hZMmFUSU0ycl9n
Myles - Any thoughts on our silence about US operations and application to FDA etc?
Do you feel we will focus first on the UK or that Cytiva under their name will license and handle the regulatory matters? The original partnership RNS seems to indicate they would also handle validation etc.
This thread adds meat to the bone. Especially Alistair’s comments - “ we will be putting in place other test strip manufacturung partners and OEM partners because the production capacity (Cytiva), given what we expect the demand for this rapid antigen test to be, cannot be supported with a single partner (Cytiva)."
https://twitter.com/bigbitenow/status/1303605913648062464?s=21
Can I ask / do people think that we are waiting for U.K. approvals before going to the US?
Considering the urgency of the situation is just doesn’t add up...
Would make more sense that Cytiva are quietly working on the US approvals..
Any reasoning post is ruined by the Neanderthals that roam these boards. Sigh.
It all adds up to me.
The Original RNS Says -
“both companies (plural) will *** work together *** to complete analytical and *** clinical validation *** of the test as quickly as possible”
The RNS present a partnership for development & validation.
I really wouldn’t be surprised if Cytiva lead operations in the US, submitting to FDA & LFT is sold under the Cytiva / Danaher brand.
What always surprised me is why don’t Cytiva make their own test. If Mologic can do it I’m not sure why they can’t...They obviously have the expertise / so do they not need to because they have collaborated?
We’ve been wondering why Cytiva have never been confirmed as manufacturer but at the beginning it was always the assumption we’d just be paid royalties for use of the affimers...
Until we learnt that actually we’d have commercial rights to the test... Which was a nice surprise to some.
===•
Just reading the original RNS and it’s all there....
Avacta Group plc (AIM: AVCT), the developer of Affimer(R) biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences. The ***companies (PLURAL) *** will develop and *** manufacture *** an Affimer-based point-of-care rapid test intended for screening of large populations to diagnose the COVID-19 coronavirus infection.
...
Cytiva will transfer this diagnostic assay onto its proprietary point-of-care test strip platform and both companies (plural) will *** work together *** to complete analytical and *** clinical validation *** of the test as quickly as possible.
Avacta will own the intellectual property relating to the COVID-19 Affimer-*** reagents *** and will retain all the commercial rights to future products.
*** Added to highlight relevant points ...
Read every one of our RNS -
“Avacta in partnership with Cytiva”
The test “ being developed with Cytiva.“
Sona don’t mention them...
It may be Sona however I’ve not seen in any of Sonas news releases mention Danaher or Cytiva...
Every single one of Avactas RNS mentions Cytiva.
The Sona news release clearly states that Sona will be applying to the FDA under their own name.
https://sonanano.com/sona-nanotech-announces-clinical-evaluation-study-results-for-its-covid-19-antigen-test/
Ps video in the link ^
Danaher launching a point of care home test ...
Danaher is Cytiva ...
Alistair has already mentioned that Cytiva wouldn’t have enough capacity to fulfil demand but this hints that three will fulfil some demand.
Could this be why we have the brand AffiDX to license to others for production?
Quickest way through the US regs is under the name of a well recognised pharma...
https://twitter.com/buy_buy_bye/status/1303455998275989505?s=21
Today was taken down to fill the large sell order £446k or so - 15.6m odd shares...
There was a gap on the chart around 2.85 and once the sell cleared it bounced off this point. Would be surprised if the share priced didn't recover.
Also remember that this has been some rise over the last month.
The future looks very bright here... Stop worrying.
Interestingly this is actually a licensed SD bio test they look to be rebranding as their own.
http://go.roche.com/ag-tw
The launch is a partnership with SD Biosensor Inc., with whom Roche has a global distribution agreement and had also launched a Rapid Antibody Test in July.